This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (287)  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

The Standard Treatment with Alteplase to Reverse Stroke (STARS) Study

Gregory W. Albers, MD; Vernice E. Bates, MD; Wayne M. Clark, MD; Rodney Bell, MD; Piero Verro, MD; Scott A. Hamilton, PhD

JAMA. 2000;283:1145-1150.

Context  Tissue-type plasminogen activator (tPA) is the only therapy for acute ischemic stroke approved by the Food and Drug Administration.

Objective  To assess the safety profile and to document clinical outcomes and adverse events in patients treated with intravenous tPA for acute stroke in clinical practice.

Design and Setting  Prospective, multicenter study of consecutive patients enrolled between February 1997 and December 1998 at 57 medical centers in the United States (24 academic and 33 community).

Intervention  Intravenous tPA (recombinant alteplase).

Patients  Three hundred eighty-nine patients with a mean age of 69 years (range, 28-100 years); 55% were men.

Main Outcome Measures  Time intervals between stroke symptom onset, hospital arrival, and treatment with tPA; pretreatment computed tomographic scan results, intracerebral hemorrhage, and major systemic bleeding. The modified Rankin Scale score was used to assess clinical outcomes at 30 days.

Results  Median time from stroke onset to treatment was 2 hours 44 minutes, and the median baseline National Institutes of Health Stroke Scale score was 13. The 30-day mortality rate was 13%. At 30 days after treatment, 35% of patients had very favorable outcomes (modified Rankin score, 0-1) and 43% were functionally independent (modified Rankin score, 0-2). Thirteen patients (3.3%) experienced symptomatic intracerebral hemorrhage, including 7 who died. Twenty-eight patients (8.2%) had asymptomatic intracerebral hemorrhage within 3 days of treatment with tPA. Protocol violations were reported for 127 patients (32.6%), and included treatment with tPA more than 3 hours after symptom onset in 13.4%, treatment with anticoagulants within 24 hours of tPA administration in 9.3%, and tPA administration despite systolic blood pressure exceeding 185 mm Hg in 6.7%. A multivariate analysis found predictors of favorable outcome to be a less severe baseline National Institutes of Health Stroke Scale score, absence of specific abnormalities (effacement or hypodensity of >33% of the middle cerebral artery territory or a hyperdense middle cerebral artery) on the baseline computed tomographic scan, an age of 85 years or younger, and a lower mean arterial pressure at baseline.

Conclusions  This study, conducted at multiple institutions throughout the United States, suggests that favorable clinical outcomes and low rates of symptomatic intracerebral hemorrhage can be achieved using tPA for stroke treatment.

Author Affiliations: Stanford Stroke Center, Stanford University Medical Center, Palo Alto, Calif (Dr Albers); Dent Neurological Institute, Millard Fillmore Hospital, Buffalo, NY (Dr Bates); Oregon Stroke Center, Oregon Health Sciences Center, Portland, (Dr Clark); Thomas Jefferson University, Philadelphia, Pa (Dr Bell); Seton Hall University, Edison, NJ (Dr Verro); and Genentech Inc, San Francisco, Calif (Dr Hamilton).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Routine Use of Intravenous Low-Dose Recombinant Tissue Plasminogen Activator in Japanese Patients: General Outcomes and Prognostic Factors From the SAMURAI Register
Toyoda et al.
Stroke 2009;40:3591-3595.
ABSTRACT | FULL TEXT  

Comprehensive Overview of Nursing and Interdisciplinary Care of the Acute Ischemic Stroke Patient: A Scientific Statement From the American Heart Association
Summers et al.
Stroke 2009;40:2911-2944.
FULL TEXT  

Review of current and emerging therapies in acute ischemic stroke
Novakovic et al.
Journal of NeuroInterventional Surgery 2009;1:13-26.
ABSTRACT | FULL TEXT  

Development of the Italian Version of the National Institutes of Health Stroke Scale: It-NIHSS
Pezzella et al.
Stroke 2009;40:2557-2559.
ABSTRACT | FULL TEXT  

Resident-Based Acute Stroke Protocol Is Expeditious and Safe
Ford et al.
Stroke 2009;40:1512-1514.
ABSTRACT | FULL TEXT  

Intra-Arterial Stroke Therapy: An Assessment of Demand and Available Work Force
Cloft et al.
Am. J. Neuroradiol. 2009;30:453-458.
ABSTRACT | FULL TEXT  

Thrombolysis for ischaemic stroke and glioblastoma multiforme: a case report
Garcia et al.
BMJ Case Reports 2009;2009:bcr0620080268-bcr0620080268.
ABSTRACT | FULL TEXT  

Thrombolytic therapy with alteplase for ischaemic stroke
DTB 2009;47:14-18.
ABSTRACT | FULL TEXT  

Atherosclerotic Peripheral Vascular Disease Symposium II: Stroke Intervention: State of the Art
Alberts et al.
Circulation 2008;118:2845-2851.
FULL TEXT  

Safety Profile of Transcranial Near-Infrared Laser Therapy Administered in Combination With Thrombolytic Therapy to Embolized Rabbits
Lapchak et al.
Stroke 2008;39:3073-3078.
ABSTRACT | FULL TEXT  

Aggressive Blood Pressure-Lowering Treatment Before Intravenous Tissue Plasminogen Activator Therapy in Acute Ischemic Stroke
Martin-Schild et al.
Arch Neurol 2008;65:1174-1178.
ABSTRACT | FULL TEXT  

Antithrombotic and Thrombolytic Therapy for Ischemic Stroke: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition)
Albers et al.
Chest 2008;133:630S-669S.
ABSTRACT | FULL TEXT  

A Pilot Randomized Clinical Safety Study of Sonothrombolysis Augmentation With Ultrasound-Activated Perflutren-Lipid Microspheres for Acute Ischemic Stroke
Alexandrov et al.
Stroke 2008;39:1464-1469.
ABSTRACT | FULL TEXT  

REPRINT: Guidelines for the Management of Spontaneous Intracerebral Hemorrhage in Adults: 2007 Update: A Guideline From the American Heart Association/American Stroke Association Stroke Council, High Blood Pressure Research Council, and the Quality of Care and Outcomes in Research Interdisciplinary Working Group: The American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists.
Broderick et al.
Circulation 2007;116:e391-e413.
ABSTRACT | FULL TEXT  

Sex Disparity in the Access of Elderly Patients to Acute Stroke Care
Foerch et al.
Stroke 2007;38:2123-2126.
ABSTRACT | FULL TEXT  

Guidelines for the Management of Spontaneous Intracerebral Hemorrhage in Adults: 2007 Update: A Guideline From the American Heart Association/American Stroke Association Stroke Council, High Blood Pressure Research Council, and the Quality of Care and Outcomes in Research Interdisciplinary Working Group: The American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists.
Broderick et al.
Stroke 2007;38:2001-2023.
ABSTRACT | FULL TEXT  

Guidelines for the Early Management of Adults With Ischemic Stroke: A Guideline From the American Heart Association/American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups: The American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists.
Adams et al.
Circulation 2007;115:e478-e534.
ABSTRACT | FULL TEXT  

Guidelines for the Early Management of Adults With Ischemic Stroke: A Guideline From the American Heart Association/ American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups: The American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists
Adams et al.
Stroke 2007;38:1655-1711.
ABSTRACT | FULL TEXT  

Sex as a predictor of outcomes in patients treated with thrombolysis for acute stroke
Elkind et al.
Neurology 2007;68:842-848.
ABSTRACT | FULL TEXT  

Balloon Catheter Disruption of Middle Cerebral Artery Thrombus in Conjunction with Thrombolysis for the Treatment of Acute Middle Cerebral Artery Embolism
Ikushima et al.
Am. J. Neuroradiol. 2007;28:513-517.
ABSTRACT | FULL TEXT  

Symptomatic intracranial haemorrhage after intra-arterial thrombolysis in acute ischaemic stroke: assessment of 294 patients treated with urokinase
Brekenfeld et al.
J. Neurol. Neurosurg. Psychiatry 2007;78:280-285.
ABSTRACT | FULL TEXT  

Association of Pretreatment Blood Pressure With Tissue Plasminogen Activator-Induced Arterial Recanalization in Acute Ischemic Stroke
Tsivgoulis et al.
Stroke 2007;38:961-966.
ABSTRACT | FULL TEXT  

Site of Arterial Occlusion Identified by Transcranial Doppler Predicts the Response to Intravenous Thrombolysis for Stroke
Saqqur et al.
Stroke 2007;38:948-954.
ABSTRACT | FULL TEXT  

Hemorrhagic Complications After Off-Label Thrombolysis for Ischemic Stroke
Aleu et al.
Stroke 2007;38:417-422.
ABSTRACT | FULL TEXT  

Two Tales: Hemorrhagic Transformation but Not Parenchymal Hemorrhage After Thrombolysis Is Related to Severity and Duration of Ischemia: MRI Study of Acute Stroke Patients Treated With Intravenous Tissue Plasminogen Activator Within 6 Hours
Thomalla et al.
Stroke 2007;38:313-318.
ABSTRACT | FULL TEXT  

Efficacy and Safety of Anticoagulant Treatment in Acute Cardioembolic Stroke: A Meta-Analysis of Randomized Controlled Trials
Paciaroni et al.
Stroke 2007;38:423-430.
ABSTRACT | FULL TEXT  

Self-Expanding Versus Balloon-Mounted Stents for Vessel Recanalization Following Embolic Occlusion in the Canine Model: Technical Feasibility Study
Levy et al.
Am. J. Neuroradiol. 2006;27:2069-2072.
ABSTRACT | FULL TEXT  

Early Recurrent Ischemic Stroke in Stroke Patients Undergoing Intravenous Thrombolysis
Georgiadis et al.
Circulation 2006;114:237-241.
ABSTRACT | FULL TEXT  

Quality improvement in acute stroke: The New York State Stroke Center Designation Project.
Gropen et al.
Neurology 2006;67:88-93.
ABSTRACT | FULL TEXT  

Comparison of Tissue Plasminogen Activator Administration Management Between Telestroke Network Hospitals and Academic Stroke Centers: The Telemedical Pilot Project for Integrative Stroke Care in Bavaria/Germany
Audebert et al.
Stroke 2006;37:1822-1827.
ABSTRACT | FULL TEXT  

Alteplase at 0.6 mg/kg for Acute Ischemic Stroke Within 3 Hours of Onset: Japan Alteplase Clinical Trial (J-ACT) * Supplemental Appendix 2
Yamaguchi et al.
Stroke 2006;37:1810-1815.
ABSTRACT | FULL TEXT  

Reasons why few patients with acute stroke receive tissue plasminogen activator.
Bambauer et al.
Arch Neurol 2006;63:661-664.
ABSTRACT | FULL TEXT  

Is IV tissue plasminogen activator beneficial in patients with hyperdense artery sign?
Qureshi et al.
Neurology 2006;66:1171-1174.
ABSTRACT | FULL TEXT  

Imaging-guided acute ischemic stroke therapy: From "time is brain" to "physiology is brain".
Gonzalez
Am. J. Neuroradiol. 2006;27:728-735.
ABSTRACT | FULL TEXT  

Thrombolysis for acute stroke with special emphasis on the very old: experience from a single Dutch centre.
van Oostenbrugge et al.
J. Neurol. Neurosurg. Psychiatry 2006;77:375-377.
ABSTRACT | FULL TEXT  

Part 9: Adult Stroke
Circulation 2005;112:IV-111-IV-120.
FULL TEXT  

Mechanical Thrombectomy Following Intravenous Thrombolysis in the Treatment of Acute Stroke
Lansberg et al.
Arch Neurol 2005;62:1763-1765.
ABSTRACT | FULL TEXT  

Intravenous rt-PA for acute stroke: comparing its effectiveness in younger and older patients
Mouradian et al.
J. Neurol. Neurosurg. Psychiatry 2005;76:1234-1237.
ABSTRACT | FULL TEXT  

Interventional neuroradiology
Renowden
J. Neurol. Neurosurg. Psychiatry 2005;76:iii48-iii63.
FULL TEXT  

MRI Screening Before Standard Tissue Plasminogen Activator Therapy Is Feasible and Safe
Kang et al.
Stroke 2005;36:1939-1943.
ABSTRACT | FULL TEXT  

Houston Paramedic and Emergency Stroke Treatment and Outcomes Study (HoPSTO)
Wojner-Alexandrov et al.
Stroke 2005;36:1512-1518.
ABSTRACT | FULL TEXT  

Adverse Events and Treatment Completion for Latent Tuberculosis in Jail Inmates and Homeless Persons
Lobato et al.
Chest 2005;127:1296-1303.
ABSTRACT | FULL TEXT  

Is Thrombolytic Therapy Associated With Increased Mortality?: Meta-analysis of Randomized Controlled Trials
Ergin and Ergin
Arch Neurol 2005;62:362-366.
ABSTRACT | FULL TEXT  

Arterial Occlusion Revealed by CT Angiography Predicts NIH Stroke Score and Acute Outcomes after IV tPA Treatment
Sims et al.
Am. J. Neuroradiol. 2005;26:246-251.
ABSTRACT | FULL TEXT  

tPA by telephone: Extending the benefits of a comprehensive stroke center
Frey et al.
Neurology 2005;64:154-156.
ABSTRACT | FULL TEXT  

Ultrasound-Enhanced Systemic Thrombolysis for Acute Ischemic Stroke
Alexandrov et al.
NEJM 2004;351:2170-2178.
ABSTRACT | FULL TEXT  

Findings From the Reanalysis of the NINDS Tissue Plasminogen Activator for Acute Ischemic Stroke Treatment Trial
Ingall et al.
Stroke 2004;35:2418-2424.
ABSTRACT | FULL TEXT  

Antithrombotic and Thrombolytic Therapy for Ischemic Stroke: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy
Albers et al.
Chest 2004;126:483S-512S.
ABSTRACT | FULL TEXT  

Catheter-Based Treatment for Patients With Acute Ischemic Stroke Ineligible for Intravenous Thrombolysis
Ramee et al.
Stroke 2004;35:e109-e111.
ABSTRACT | FULL TEXT  

Improving the Predictive Accuracy of Recanalization on Stroke Outcome in Patients Treated With Tissue Plasminogen Activator
Molina et al.
Stroke 2004;35:151-156.
ABSTRACT | FULL TEXT  

Tissue Plasminogen Activator for Acute Ischemic Stroke in Clinical Practice: A Meta-Analysis of Safety Data
Graham
Stroke 2003;34:2847-2850.
ABSTRACT | FULL TEXT  

Assessment of the Patient with Hyperacute Stroke: Imaging and Therapy
Provenzale et al.
Radiology 2003;229:347-359.
ABSTRACT | FULL TEXT  

Brains, claims, and the pharmaceutical industry
Alberts et al.
BMJ 2003;327:E107-109.
FULL TEXT  

Feasibility of Neuroprotective Agent Administration by Prehospital Personnel in an Urban Setting
Crocco et al.
Stroke 2003;34:1918-1922.
ABSTRACT | FULL TEXT  

Expanded Modes of Tissue Plasminogen Activator Delivery in a Comprehensive Stroke Center Increases Regional Acute Stroke Interventions
Rymer et al.
Stroke 2003;34 :e58-e60.
ABSTRACT | FULL TEXT  

Impact of Establishing a Primary Stroke Center at a Community Hospital on the Use of Thrombolytic Therapy: The NINDS Suburban Hospital Stroke Center Experience
Lattimore et al.
Stroke 2003;34 :e55-e57.
ABSTRACT | FULL TEXT  

Sensitivity and Interrater Agreement of CT and Diffusion-Weighted MR Imaging in Hyperacute Stroke
Saur et al.
Am. J. Neuroradiol. 2003;24:878-885.
ABSTRACT | FULL TEXT  

Frequency of Thrombolytic Therapy in Patients With Acute Ischemic Stroke and the Risk of In-Hospital Mortality: The German Stroke Registers Study Group
Heuschmann et al.
Stroke 2003;34:1106-1112.
ABSTRACT | FULL TEXT  

Pre- and In-Hospital Delays From Stroke Onset to Intra-arterial Thrombolysis
Nedeltchev et al.
Stroke 2003;34:1230-1234.
ABSTRACT | FULL TEXT  

Guidelines for the Early Management of Patients With Ischemic Stroke: A Scientific Statement From the Stroke Council of the American Stroke Association
Adams et al.
Stroke 2003;34:1056-1083.
FULL TEXT  

Quality Improvement and Tissue-Type Plasminogen Activator for Acute Ischemic Stroke: A Cleveland Update
Katzan et al.
Stroke 2003;34:799-800.
ABSTRACT | FULL TEXT  

Inhibition of Factor Xa Reduces Ischemic Brain Damage After Thromboembolic Stroke in Rats
Wang et al.
Stroke 2003;34:468-474.
ABSTRACT | FULL TEXT  

Imaging-Based Decision Making in Thrombolytic Therapy for Ischemic Stroke: Present Status
Schellinger et al.
Stroke 2003;34:575-583.
ABSTRACT | FULL TEXT  

Analysis of the Safety and Efficacy of Intra-Arterial Thrombolytic Therapy in Ischemic Stroke
Lisboa et al.
Stroke 2002;33:2866-2871.
ABSTRACT | FULL TEXT  

Prevalence of Atrial Fibrillation and Antithrombotic Prophylaxis in Emergency Department Patients
Scott et al.
Stroke 2002;33:2664-2669.
ABSTRACT | FULL TEXT  

Atrial Fibrillation, Stroke, and Acute Antithrombotic Therapy: Analysis of Randomized Clinical Trials
Hart et al.
Stroke 2002;33:2722-2727.
ABSTRACT | FULL TEXT  

Effect of Intravenous Thrombolysis on MRI Parameters and Functional Outcome in Acute Stroke <6 Hours
Rother et al.
Stroke 2002;33:2438-2445.
ABSTRACT | FULL TEXT  

Thrombolysis for Acute Stroke in Routine Clinical Practice
Bravata et al.
Arch Intern Med 2002;162:1994-2001.
ABSTRACT | FULL TEXT  

CT and Conventional and Diffusion-weighted MR Imaging in Acute Stroke: Study in 691 Patients at Presentation to the Emergency Department
Mullins et al.
Radiology 2002;224:353-360.
ABSTRACT | FULL TEXT  

Clinical and Vascular Outcome in Internal Carotid Artery Versus Middle Cerebral Artery Occlusions After Intravenous Tissue Plasminogen Activator
Linfante et al.
Stroke 2002;33:2066-2071.
ABSTRACT | FULL TEXT  

Toward Wisdom From Failure: Lessons From Neuroprotective Stroke Trials and New Therapeutic Directions
Gladstone et al.
Stroke 2002;33:2123-2136.
ABSTRACT | FULL TEXT  

Extrapolation of Correlation Between 2 Variables in 4 General Medical Journals
Kuo
JAMA 2002;287:2815-2817.
ABSTRACT | FULL TEXT  

Can Transcranial Ultrasonication Increase Recanalization Flow With Tissue Plasminogen Activator?
Ishibashi et al.
Stroke 2002;33:1399-1404.
ABSTRACT | FULL TEXT  

Markers of Increased Risk of Intracerebral Hemorrhage After Intravenous Recombinant Tissue Plasminogen Activator Therapy for Acute Ischemic Stroke in Clinical Practice: The Multicenter rt-PA Acute Stroke Survey
Tanne et al.
Circulation 2002;105:1679-1685.
ABSTRACT | FULL TEXT  

Cardiovascular Disease Among Women Residing in Rural America: Epidemiology, Explanations, and Challenges
Taylor et al.
AJPH 2002;92:548-551.
ABSTRACT | FULL TEXT  

Is the Association of National Institutes of Health Stroke Scale Scores and Acute Magnetic Resonance Imaging Stroke Volume Equal for Patients With Right- and Left-Hemisphere Ischemic Stroke?
Fink et al.
Stroke 2002;33:954-958.
ABSTRACT | FULL TEXT  

Extending Tissue Plasminogen Activator Use to Community and Rural Stroke Patients
Merino et al.
Stroke 2002;33:141-146.
ABSTRACT | FULL TEXT  

Improving Delivery of Acute Stroke Therapy: The TLL Temple Foundation Stroke Project
Morgenstern et al.
Stroke 2002;33:160-166.
ABSTRACT | FULL TEXT  

Adherence to Postacute Rehabilitation Guidelines Is Associated With Functional Recovery in Stroke * Editorial Comment
Duncan et al.
Stroke 2002;33:167-178.
ABSTRACT | FULL TEXT  

Lack of Clinical Significance of Early Ischemic Changes on Computed Tomography in Acute Stroke
Patel et al.
JAMA 2001;286:2830-2838.
ABSTRACT | FULL TEXT  

Intravenous Tissue-Type Plasminogen Activator Therapy for Ischemic Stroke: Houston Experience 1996 to 2000
Grotta et al.
Arch Neurol 2001;58:2009-2013.
ABSTRACT | FULL TEXT  

Cerebral hemorrhage after intra-arterial thrombolysis for ischemic stroke: The PROACT II trial
Kase et al.
Neurology 2001;57:1603-1610.
ABSTRACT | FULL TEXT  

Dehydroascorbic acid, a blood-brain barrier transportable form of vitamin C, mediates potent cerebroprotection in experimental stroke
Huang et al.
Proc. Natl. Acad. Sci. USA 2001;98:11720-11724.
ABSTRACT | FULL TEXT  

Characteristics of Academic Medical Centers and Ischemic Stroke Outcomes
Gillum and Johnston
Stroke 2001;32:2137-2142.
ABSTRACT | FULL TEXT  

Advances in intravenous thrombolytic therapy for treatment of acute stroke
Albers
Neurology 2001;57:S77-81.
ABSTRACT | FULL TEXT  

Predictors of good outcome after intravenous tPA for acute ischemic stroke
Demchuk et al.
Neurology 2001;57:474-480.
ABSTRACT | FULL TEXT  

Update on intravenous tissue plasminogen activator for acute stroke: from clinical trials to clinical practice
Gladstone and Black
CMAJ 2001;165:311-317.
ABSTRACT | FULL TEXT  

Treatment With Tissue Plasminogen Activator and Inpatient Mortality Rates for Patients With Ischemic Stroke Treated in Community Hospitals Editorial Comment
Reed et al.
Stroke 2001;32:1832-1840.
ABSTRACT | FULL TEXT  

Intravenous tPA for Ischemic Stroke Team Performance Over Time, Safety, and Efficacy in a Single-Center, 2-Year Experience
Koennecke et al.
Stroke 2001;32:1074-1078.
ABSTRACT | FULL TEXT  

Why are stroke patients excluded from TPA therapy?: An analysis of patient eligibility
Barber et al.
Neurology 2001;56:1015-1020.
ABSTRACT | FULL TEXT  

Initial Angiographic Appearance of Intracranial Vascular Occlusions in Acute Stroke as a Predictor of Outcome of Thrombolysis: Initial Experience
Pillai et al.
Radiology 2001;218:733-738.
ABSTRACT | FULL TEXT  

Thrombolysis in acute ischaemic stroke
Pereira et al.
Postgrad. Med. J. 2001;77:166-171.
FULL TEXT  

Human Albumin Therapy of Acute Ischemic Stroke : Marked Neuroprotective Efficacy at Moderate Doses and With a Broad Therapeutic Window
Belayev et al.
Stroke 2001;32:553-560.
ABSTRACT | FULL TEXT  

Intraarterial Thrombolysis: Ready for Prime Time?
COMMITTEE OF THE ASITN
Am. J. Neuroradiol. 2001;22:55-58.
FULL TEXT  

Antithrombotic and Thrombolytic Therapy for Ischemic Stroke
Albers et al.
Chest 2001;119 :300S-320S.
FULL TEXT  

Can emergency department physicians safely and effectively initiate thrombolysis for acute ischemic stroke?
Akins et al.
Neurology 2000;55:1801-1805.
ABSTRACT | FULL TEXT  

Intravenous Tissue Plasminogen Activator for Acute Ischemic Stroke : A Canadian Hospital's Experience
Chapman et al.
Stroke 2000;31:2920-2924.
ABSTRACT | FULL TEXT  

An Overview of Acute Stroke Therapy: Past, Present, and Future
Fisher and Schaebitz
Arch Intern Med 2000;160:3196-3206.
FULL TEXT  

Thrombolytic Therapy in Patients With Acute Ischemic Stroke
Hinchey and Benesch
Arch Neurol 2000;57:1430-1436.
FULL TEXT